Protein expression profiles indicative for drug resistance of kidney carcinoma

Cancer Genomics and Proteomics

Volumn 1, Issue 1, 2004, Pages 17-22

  Efferth, Thomas ^a   Volm, Manfred ^b  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

Author keywords

Cytostatic agents; Drug resistance; Hierarchical cluster analysis; Kidney carcinoma; Protein expression

Indexed keywords

EID: 34247388416     PISSN: 11096535     EISSN: 17906245     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Deffie AM, Alam T, Seneviratne C, Beenken SW, Batra JK, Shea TC, Henner WD and Goldenberg GJ: Multifactorial resistance to adriamycin: relationship of DNA repair, glutathione transferase activity, drug efflux, and P-glycoprotein in cloned cell lines of adriamycin-sensitive and -resistant P388 leukemia. Cancer Res 48: 3595-3602, 1988.
2. Volm M, Mattern J, Efferth T and Pommerenke EW: Expression of several resistance mechanisms in untreated human kidney and lung carcinomas. Anticancer Res 12: 1063-1068, 1992.
3. Volm M and Rittgen W: Cellular predictive factors for the drug response of lung cancer. Anticancer Res 20: 3449-3458, 2000.
4. Volm M, Koomägi R, Mattern J and Efferth T: Protein expression profiles indicative for drug resistance of non-small cell lung carcinomas. Br J Cancer 87: 251-257, 2002.
5. Efferth T, Löhrke H and Volm M: Reciprocal correlation between expression of P-glycoprotein and accumulation of rhodamine 123 in human tumors. Anticancer Res 9: 1633-1638, 1989.
6. Efferth T and Volm M: Modulation of P-glycoprotein-mediated multidrug resistance by monoclonal antibodies, immunotoxins or antisense oligodeoxynucleotides in kidney carcinoma and normal kidney cells. Oncology 50: 303-308, 1993.
7. Group of Sensitivity Testing of Tumors (KSST): In vitro shortterm test to determine the resistance of human tumors to chemotherapy. Cancer 48: 2127-2135, 1981.
8. Volm M: Short-term incubation test. Cancer Campaign (Ed. Grundmann E) Vol. 7: Carcinoma of the Ovary. G. Fischer Verlag, 1983, p. 71-81.
9. Volm M, Efferth T, Bak M, Ho AD and Mattern J: Detection of the multidrug resistant phenotype in human tumors by monoclonal antibodies and the streptavidin-biotinylated phycoerythrin complex method. Eur J Cancer Clin Oncol 25: 743-749, 1989.
10. Efferth T and Volm M: Immunohistological detection of Pglycoprotein 170 in multidrug resistant cells. Comparison of different methods. Tumor Diagn Ther 11: 33-36, 1990.
11. Volm M, Koomägi R, Mattern J and Efferth T: Expression profiles of genes in non-small cell lung carcinomas from longterm surviving patients. Clin Cancer Res 8: 1843-1848, 2002.
12. Volm M, Koomägi R, Mattern J and Efferth T: Protein expression profile of primary human squamous cell lung carcinomas indicative of the incidence of metastases. Clin Exp Metast 19: 385-390, 2002.
13. Efferth T, Koomägi R, Mattern J and Volm M: Expression profile involved in the xenotransplantability of non-small cell lung cancers into athymic nude mice. Int J Oncol 20: 391-395, 2002.
14. Volm M, Sauerbrey A, Zintl F, Koomägi R and Efferth T: Protein expression profile of newly diagnosed acute lymphoblastic leukemia in children developing relapses. Oncol Rep 9: 965-969, 2002.
15. Efferth T, Mattern J and Volm M: Immunohistochemical detection of P-glycoprotein, glutathione S-transferase and DNA topoisomerase II in human tumors. Oncology 49: 368-375, 1992.
16. Efferth T and Volm M: Expression of protein kinase C in human renal cell carcinoma cells with inherent resistance to doxorubicin. Anticancer Res 12: 2209-2212, 1992.
17. Efferth T and Volm M: Increase of alkaline phosphatase in multidrug-resistant tumor cells and their cross-resistance to 6-thioguanine. Arzneimittelforschung 43: 1118-1121, 1993.
18. Wolpert MK, Damle SP, Brown JE, Sznycer E, Agrawal KC and Sartorelli AC: The role of phosphohydrolases in the mechanism of resistance of neoplastic cells to 6-thiopurines. Cancer Res 31: 1620-1626, 1971.
19. Posada J, Vichi P and Tritton TR: Protein kinase C in adriamycin action and resistance in mouse sarcoma 180 cells. Cancer Res 49: 6634-6639, 1989.
20. el-Deiry WS: Role of oncogenes in resistance and killing by cancer therapeutic agents. Curr Opin Oncol 9: 79-87, 1997.
21. Wooster R: Cancer classification with DNA microarrays. Is less more? Trends Genet 16: 327-329, 2000.